Physician profile
Anthony Viscon
NPI 1447809884
$568.28
in general payments reported to CMS, 2019-2025
8 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.00 · 2024: $24.86 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $157.12 | 2025 | Xphozah 30 Mg, Ibsrela |
| Glaxosmithkline, LLC. | $124.11 | 2025 | Benlysta |
| Bayer Healthcare Pharmaceuticals INC. | $103.52 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $76.14 | 2025 | Farxiga, Lokelma |
| Novo Nordisk INC | $54.56 | 2025 | Ozempic, Wegovy |
| Becton, Dickinson and Company | $18.00 | 2021 | |
| Scpharmaceuticals INC. | $17.89 | 2025 | |
| Calliditas Therapeutics US INC. | $16.94 | 2025 | Tarpeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Viscon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.